FGFR1 and central nervous system cancer: Sporadic cases harboring other missense mutations (as the double mutant K656E/T658P) might share common mechanisms with the ones uncovered in the present work, thus enlightening why DNETs and other therapy naive gliomas with a quiet genome acquire additional hits involving the FGFR1 gene.